
Rep. Glenn Grothman @RepGrothman
The 340B Drug Pricing Program has made life-saving medications more readily available to patients, while saving them money. I asked the CEO of Novartis if the company has been a good steward of this program. @340BHealth https://t.co/fLCzvBAs2j — PolitiTweet.org